Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed NIF Ventures Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
NIF Ventures is the venture capital and private equity arm of the Daiwa Securities Group. It specializes in early- and later-stage investments. The firm was established in Tokyo in 1982 and has invested in more than 1,560 private companies and assisted more than 460 investees with IPOs. It currently manages approximately $1 billion in funds globally for its shareholders and limited partners.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2000 | HENNGE | Series A | - |
| 1/2004 | Cyclacel Pharmaceuticals | Series D | 38.7M |
| 9/2000 | Sharing Technologies | Series C | 9M |
| 10/2000 | Wavesplitter | Venture Round | 51M |
| 9/1999 | Wavesplitter | Venture Round | 21M |
| 10/2004 | BioXell | Series C | 29M |
| 1/2001 | Cyan Technology Ltd | Venture Round | 2M |
| 7/2000 | eFinance.com | Series A | 0 |
| 3/2002 | Wavesplitter | Venture Round | 20M |
| 4/2001 | Antenova | Series A | 4.9M |
| 7/2000 | Kanisa | Series D | 18M |
| 8/2001 | Kanisa | Series E | 30M |
| 10/2003 | Anadigm | Series C | 15M |
| 2/2001 | HENNGE | Series C | - |
| 5/2004 | Kleer | Series A | 6M |
| 5/2002 | SatisFusion | Series C | 1.6M |
| 1/2000 | Simpata Inc | Series B | 20M |
| 11/2001 | Accelight Networks | Venture Round | 60M |
| 10/2003 | Arrow Therapeutics | Series B | 34.9M |
| 3/2005 | TorreyPines Therapeutics | Series C | 0 |
| 5/2004 | Plexxikon | Series B | 0 |
| 7/2003 | Elixent | Series B | 10M |
| 5/2001 | Netcontinuum | Series B | 26M |
| 2/2002 | Cyan Technology Ltd | Series B | 2.8M |
| 1/2002 | On Demand Distribution (OD2) | Venture Round | 5.7M |
| 9/2000 | HENNGE | Series B | - |
| 5/2004 | Psytechnics | Series C | 11.6M |
| 7/2001 | Vpacket Communications | Series C | 40M |
| 8/2001 | AccessLan Communications | Venture Round | 16M |
| 4/2003 | Oxxon Therapeutics | Venture Round | 0 |
| 8/2006 | Psytechnics | Venture Round | - |
| 3/2005 | Tolerx | Series D | 31M |
| 9/2002 | SpectraSwitch | Series C | 7.5M |
| 10/2006 | Tolerx | Series D | 61M |
| 8/2005 | Intercytex Group | Series D | 0 |
| 1/2002 | SpectraSwitch | Series B | 6M |
| 4/2005 | Elixent | Series C | 15M |
| 9/2003 | Kanisa | Venture Round | 13M |
| 12/2004 | Escend Technologies | Series D | 3M |
| 6/2002 | Escend Technologies | Series C | 5.4M |
| 10/2006 | Tolerx | Series D | 0 |
| 8/2006 | Psytechnics | Venture Round | - |
| 8/2005 | Intercytex Group | Series D | 0 |
| 4/2005 | Elixent | Series C | 0 |
| 3/2005 | Tolerx | Series D | 0 |
| 3/2005 | TorreyPines Therapeutics | Series C | 0 |
| 12/2004 | Escend Technologies | Series D | 0 |
| 10/2004 | BioXell | Series C | 0 |
| 5/2004 | Psytechnics | Series C | 0 |
| 5/2004 | Plexxikon | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
